Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04876092
Title A Study of the MALT1 Inhibitor JNJ-67856633 and Ibrutinib in B-cell NHL and CLL
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Janssen Research & Development, LLC
Indications
Therapies
Age Groups: senior | adult
Covered Countries SWE | POL | FRA | DNK

Facility Status City State Zip Country Details
Rigshospitalet Copenhagen 2100 Denmark Details
CHRU de Lille Hopital Claude Huriez Lille 59037 France Details
Institut Paoli Calmettes Marseille 13009 France Details
CHU de Nantes hotel Dieu Nantes 44000 France Details
Hopital St Louis Paris 75475 France Details
CHU de Bordeaux - Hospital Haut-Leveque Pessac 33600 France Details
Gustave Roussy Villejuif Cedex 94800 France Details
Pratia MCM Krakow Krakow 30 727 Poland Details
Centrum Medyczne Pratia Poznan Skorzewo 60-185 Poland Details
Universitetssjukhuset Lund, Onkologiska Kliniken, Lund Lund 221 85 Sweden Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field